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Recently many researches have been carried out on Malacca fruit extract and its potential 
protective effect on in vivo organ toxicity. However, there is still no research on the protective 
effect of Malacca (Phyllanthus emblica L.) fruit extract on induced hepatotoxicity of anticancer 
drugs, especially doxorubicin in rats. The objective of this study is to determine the potential 
protective effect of ethanol extract of Malacca fruit (P. emblica L.) against doxorubicin-induced 
hepatotoxicity in rats. A preliminary phytochemical test was done followed by administration 
extract into doxorubicin-induced rats. Histological studies were carried out to observe the effect of 
the extract on liver tissue. Phytochemical test results show that the ethanol extract of Malacca fruit 
contains flavonoids, phenols, tannins, triterpenoids, terpenoids, and alkaloids. The increasing value 
of ALT and ALP of doxorubicin-induced liver tissue proved the toxicity in liver tissue caused by 
doxorubicin. The ethanol extract of P. emblica L. at dosage 200 mg/kg BW and dosage 400 mg/kg 
BW on doxorubicin-induced rats were successfully played as an antioxidant to decrease the ALT 
and ALP values and improve liver tissue doxorubicin-induced by normal hepatocytes more 
dominant than lysis and less mark of bleeding and congestion of blood vessels. 
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Based on WHO data in 2008, there are as many as 36 million people in the world who suffer 
from Non-Communicable Diseases (NCD) of the 57 million people who died. The proportion of 
causes of death of NCD in people aged less than 70 years is cardiovascular disease (39%), cancer 
(27%), lung disease - chronic respiratory and gastrointestinal diseases each cause 30% of deaths, 
and the rest is caused by diabetes mellitus (WHO, 2010). According to the WHO, deaths caused by 
NCD are expected to increase continuously throughout the world, with the proportion most often 
found in groups of developing countries. In 2030, there will be a real epidemiological transition 
globally, at regional and national levels with a shift in the number of cases of infectious diseases to 
degenerative diseases and NCDs, including cancer, diabetes, and heart disease. The increase in the 
incidence of degenerative diseases is thought to be related to lifestyle risk factors, population 
growth, and increased life expectancy (Kementerian Kesehatan Republik Indonesia, 2013). 
In cancer patients, organ dysfunction is a frequent phenomenon, especially impaired liver 
function is the most common case and is one of the factors considered in cancer patients’ treatment. 
Doxorubicin (adriamycin), an anthracycline class, is an anticancer drug widely used to treat broad-
spectrum cancer patients. Several studies have found hepatotoxicity found in cancer patients, 
mostly due to the toxicity of the anticancer drugs used, including the use of doxorubicin and a 
small part due to a history of previous hepatic abnormalities (Damodar et al., 2014). Damodar et al. 
(2014) reported that there was a strong correlation to the occurrence of hepatotoxicity in breast 
cancer patients who received doxorubicin injection, where 30.4% of breast cancer patients 
experienced hepatotoxicity marked by an increase in serum glutamic oxaloacetic transaminase 
(SGOT), serum glutamic pyruvic transaminase (SGPT), direct bilirubin levels, and total bilirubin 
levels (Damodar et al., 2014). King and Perry (2001) suggested that the use of doxorubicin will 
affect cell membrane function through DNA intercalation and free radical formation in hepatocytes 
(Injac and Strukelj, 2008; King and Perry, 2001). Furthermore, Pedrycz et al. (2004) found that 
doxorubicin can cause apoptosis of hepatocyte cells in adult rats. Although the underlying 
mechanism is unclear, it is thought to be related to the production of free radicals and oxidative 
tension that triggers cell injury, including hepatocytes and other body cells (Sliai, 2015). The 
hepatotoxicity caused by doxorubicin and the belief in its toxicity mechanism through the free 
radicals production resulted in several new approaches oriented to the natural antioxidants using. 
Many natural antioxidants have been studied for their content and benefits, such as vitamins (E, A, 
C, and carotenoids), coenzyme Q, flavonoids, polyphenols, selenium, and olive oil (Injac and 
Strukelj, 2008).  
Many plants and their extracts have a hepatoprotective effect by increasing their antioxidant 
status so that plant-derived drugs play an essential role in managing a liver disease or disorders 
(Seif, 2016). The Indian gooseberry or Malacca (Phyllanthus emblica L.) contains high content of 
tannins, flavonoids, phenolic compounds, saponins, terpenoids, ascorbic acid, carbohydrates, and 
other compounds (Hasan et al., 2016). The content of total phenol compounds (TPC), mostly of 
gallic acid, comes from the Malacca fruit and seed. TPC is a potent antioxidant source and plays a 
vital role in scavenging free radical groups in maintaining a balance of redox potential in 
degenerative disorders (Hasan et al., 2016). The water extract of Malacca fruit in another study was 
found as a strong potential in scavenging free radicals and inhibiting the ROS (Reactive Oxygen 
Species) production (Hasan et al., 2016). Other than phenolic compounds, flavonoids as secondary 
metabolites of Malacca fruit extract have also been studied by Sharma et al. (2010). In addition, it 
was found that Malacca extract's flavonoid compounds can be used as chemotherapy agents and 
nutrition since it has excellent antioxidant potential and can be well absorbed through the 
gastrointestinal tract (Hasan et al., 2016). Studies about the hepatoprotective potential of Malacca 
fruit extract have been reported. Previously, Tasduq et al. (2005) reported that hydroalcoholic 
extract of P. emblica fruit acted as hepatoprotective against anti-tuberculosis drug-induced hepatic 
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injury in rats. The protective action was carried out through the antioxidant mechanism, membrane 
stabilizing, CYP 2E1 enzyme inhibition. Another study found that P. emblica L fruit extract with 
the dosage of 75 mg/kg per day can improve the recovery of rat liver cell by increasing the IL-1β 
levels, aspartate transaminase (AST) levels, and alanine aminotransferase (ALT) levels back to 
normal values (Charmkar and Singh, 2017). A histopathological study on the liver tissues of rats 
treated with Malacca fruit extract has also been carried out. This study used paracetamol as an 
inducer of hepatotoxicity and the result showed the ability of P. emblica L extract to reduce toxicity 
and liver damage (Hasan et al., 2016). Another study also found that the protective effect of 
hydroalcoholic extract of P. emblica L. fruit on chronic hepatoxicity induced by carbon 
tetrachloride (CCl4) and thioacetamide in rats by accelerating the regenerative activity of the liver 
cells of the rats tested (Mir et al., 2007).  
From previous studies, the hepatoprotective effect of Malacca fruit extract (P. emblica L.) on 
hepatotoxicity induced by anticancer drugs, especially doxorubicin in experimental rats, has not 
been discovered. Furthermore, it is necessary to compare the hepatoprotective effects through liver 
function tests (ALT and ALP levels) and histopathological tests of the rat’s liver tissues. Thus, the 
purpose of this study observes the potential protective effect of the  Malacca fruit (P. emblica L.) 
ethanolic extract against doxorubicin-induced hepatotoxicity in rats.  
MATERIALS AND METHOD   
Materials 
 Malacca fruits (P. emblica L.) were obtained from around Medan and were used as the 
plant materials in this study. The fruits were authenticated by a botanist from Biology Department, 
Universitas Sumatera Utara. The chemical used were acetic anhydride, iron (III) chloride, 
magnesium powder, mercury (II) chloride, potassium iodide, iodine, 2,2-diphenyl-1picrylhydrazyl 
(DPPH), bismuth (III) nitrate, hematoxylin solution, and eosin were purchased from Sigma-
Aldrich, USA. Doxorubicin-HCl was purchased from Kalbe, Indonesia. Phosphate buffer, 
chloroform, hydrochloric acid, sulfuric acid, amyl alcohol, and ethanol were obtained from Smart-
Lab, Indonesia.  
 
Experimental Animals 
 Male Wistar rats (Rattus novergicus) weighed 150-250 g (2 months old) were selected for 
this study and conditioned for 1 week to adjust to their environment. These rats were divided into 5 
groups which consisted of 5 rats in each group. This study has been passed as ethical by the Health 





The preparation and extraction of samples were determined by the previous method 
including some modifications (Nur et al., 2017).  P. emblica fruits were dried at 50
º
C for two days 
and ground into powder, resulted in 1000 g of sample powder. Fruit powder samples were extracted 
with 4000 ml of 96% ethanol (v/v) and submitted to maceration for 24 h (25˚C). Subsequently, the 
mixtures were filtered and the extraction process was repeated twice. Later, the extracts were 
concentrated at 50
º
C using a rotary evaporator and a 248 g yield of extract was obtained. 
Phytochemical screening 
The extract of P. emblica was evaluated by qualitative reactions of common plant secondary 
metabolites. The screening was carried out for flavonoids, alkaloids, tannins (Nurhasnawati et al., 
2019), saponins (Akinpelu et al., 2014), phenols (Godghate and Sawant, 2013), steroid, terpenoids 
(Edeoga et al., 2005), triterpenoid (Alabri et al., 2014). The changing of color, frothing, or 
precipitate formation was used for the test response. 
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Evaluation of hepatic biochemical markers 
The evaluation of hepatic biochemical markers has followed the previous methods with 
modification (Rahmani et al., 2018).  Twenty five male rats (R. novergicus) were weighed 200 g 
and randomly divided into 5 groups (5 rats in each group). The dosage of the P. emblica L. extract 
was given followed a previous study (Sultana et al., 2005). All foods and drinks were given the 
same to all treatment groups with no additional provision of fluids or other types of food in the 
doxorubicin group. 
 
Group A : No treatment for 14 days 








Group C :  P. emblica L. extract was given orally (200 mg/kg BW) for 14 days 
Group D : P. emblica L. extract was given orally (200 mg/kg BW) for 14 days, and doxorubicin 
for 3 days 
Group E : P. emblica L. extract was given orally (400 mg/kg BW) for 14 days, and doxorubicin 
for 3 days 
 
One day after the administration of the last dose, the mice were euthanized and the liver 
organ was immediately removed and washed with saline. Then 10% of the liver tissues were 
homogenized in buffered phosphate (pH=7.4) and centrifuged at 3000 rpm for 20 min at 4
o
C. The 
enzymatic activity alanine aminotransferase (ALT) and alkaline phosphatase (ALP) were measured 
based on the previous methods (Kanthe et al., 2017; Rahmani et al., 2018). 
 
Histological studies 
The liver histology study has done based on the previous methods by Rahmani et al., (2018) 
and Salouege et al., (2014). Small pieces of liver tissue were fixed in 10% formalin for 
histopathological studies and the tissue processing was done as a routine. Five-micron sections 
were obtained, stained with Harris Hematoxylin & Eosin, and assessed for any changes in the 
histological structure under a light microscope. Analysis was carried out qualitatively by observing 
the condition of the hepatocytes and blood vessels. 
 
Statistical Analysis 
Values were expressed in terms of Mean ± Standard error of mean (SEM). One-way 
ANOVA was done to determine the significance of inter-group differences. p<0.05 was considered 
statistically significant. 
 
RESULT AND DISCUSSION  
Phytochemical screening 
 Investigation of the natural sources as therapeutic agents cannot be separated from 
phytochemical screening techniques. This technique is used to analyze secondary metabolites 
found in plant extracts (Srivastava et al., 2014). In this study, screening tests were done 
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Table 1. The phytochemicals present in Phyllanthus emblica L. (Malacca) fruit extracts 
Compounds 
Result 
P. emblica L. extract Observation 
Alkaloids (+) Orange 
Flavonoids (+) Yellow/Orange 
Phenolics (+) Green/Blue/Black 
Steroids/Triterpenoids (+) Orange 
Terpenoids (+) Purple 
Tannins (+) Red/Orange Layer 
+ = Present, - = Absent 
Phyllanthus emblica L. (Malacca) fruit contains various bioactive chemicals. Table 1 shows 
the presence of alkaloids, flavonoids, phenolics, steroids/triterpenoids, terpenoids, and tannins. 
Previously, Sriwatcharakul (2020) and Luo et al. (2011) found that P. emblica L. seed extracts 
contained flavonoids, phenolic, tannin, saponins, and, alkaloids as secondary metabolites. 
Chaphalkar et al. (2017) also found that P. emblica L. (Malacca) bark-extract contained phenolic, 
flavonoids, and tannins. Previous findings suggested that the phytochemical of P. emblica L. 
(Malacca) have a potential effect as an anti-inflammatory (Wang et al., 2017), anti-microbial, 
antioxidant, anti-collagenase, and anti-elastase (Mayachiew and Devahastin, 2008). 
 
Biochemical results 
The hepatic biochemical markers measurement was conducted to evaluate ALT and ALP 
levels from rats with various treatments. In identifying the liver's toxicity, ALT was used as a 
marker for cytotoxic hepatic injury as it is mainly found in the liver. Along with ALT, ALP is also 
used since the elevation of this serum enzyme indicates cholestatic injury (Zimmermann-Ivol et 
al., 2004). The result of the activity of ALT and ALP present in Table 2. 
Table 2. The alanine aminotransferase (ALT) and alkaline phosphatase (ALP) enzyme 
activity in different treatments on doxorubicin-induced rats 
Treatments 
Biochemical Parameter 
ALT (U/I) ALP(U/I) 
Normal 95.60 ± 2.42 225.00 ± 12.21 
Doxorubicin, 25 mg/kg BW (Negative Control) 170.40 ± 8.58 470.00 ± 49.01 
P. emblica L extract, 200 mg/kg BW 105.80 ± 5.30 265.60 ± 26.89 
P. emblica L extract, 200 mg/kg BW + Doxorubicin 126.60 ± 8.25 397.00 ± 7.05 
P. emblica L extract, 400 mg/kg BW + Doxorubicin 118.40 ± 5.52 320.40 ± 18.92 
Table 2 shows the doxorubicin treatments increased the level of ALT and ALP to 170.40 ± 
8.58 and 470.00 ± 49.01 compared with normal treatment with 95.60 ± 2.42 and 225.00 ± 12.21 
U/I, respectively. The treatments only with P. emblica L. extract 200 mg/kg BW decreased the 
serum activity for ALT 105.80 ± 5.30 and ALP 265.60 ± 26.89, similar to normal group treatment. 
The serum liver enzyme activities reduced in the group treatments of doxorubicin with P. emblica 
L. extract 200 mg/kg BW (ALT: 126.60 ± 8.25 and ALP: 397.00 ± 7.05 U/I) and 400 mg/kg BW 
(ALT: 118.40 ± 5.52 and ALP 320.40 ± 18.92 U/I), respectively compared to doxorubicin group. 
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The increasing value of ALT and ALP indicated the toxicity of liver tissue induces by 
doxorubicin. This finding agrees with Seif (2016) which reported that ALT and ALP are the 
specific biochemical parameters to detect liver damage or injury. The increasing number of ALT 
two-times than normal indicates the damage of liver tissue (Seif, 2016). Alshabanah et al. (2010) 
also reported that doxorubicin leads to increasing serum indices of liver function such as ALT and 
ALP, leading to hepatocellular damage and decreased liver function. The administration of the 
extract at a dose of 400 mg/kg BW could reduce ALT and ALP levels compared to 200 mg/kg BW 
dose in the group of rats with hepatotoxicity. In other words, P. emblica fruit ethanol extract had 
the effect of reducing ALT and ALP levels in the rats experiencing hepatotoxicity. This finding 
agrees with a previous study where the decreasing ALP and ALP level leads to recovery of treated 
rats liver cells (Chaphalkar et al., 2017; Pramyothin et al., 2006). 
 
Histopathological results 
Histopathological examination in this study was conducted to investigate P. emblica extract 
effect in doxorubicin-induced hepatotoxicity rats. The photomicrographs of the liver tissue 
histology of all treatment groups are shown in Figure 1. 
 
Central veins  Hepatocytes Sinusoid 
Figure 1.  Photomicrographs of liver histopathology in rats from normal treatment group A), 
doxorubicin (25 mg/kg BW) only treatment group B), P. emblica extract C), P. 
emblica extract 200 mg/kg BW + doxorubicin D), and  P. emblica extract 400 mg/kg 
BW + doxorubicin E) with 400x magnification 
 
Figure 1 shows the photomicrographs from different group treatments. The normal group 
(Figure 1A) shows the normal hepatocytes, sinusoids, central veins, no interstitial bleeding, and no 
inflammatory cell infiltration. The doxorubicin group shows lysis and pyknotic cell nuclei at 
hepatocyte cells, blood vessel congestion, sinusoid interstitial bleeding, and inflammatory cell 
infiltration. In the doxorubicin group (Figure 1B), there was hepatocyte experiencing lysis and 
pyknotic cell nuclei (marked with a yellow triangle), blood vessel congestion (red triangle), and 
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sinusoid interstitial bleeding (blue triangle). P. emblica extract at 200 mg/kg BW shows the 
similarity of liver tissue to the normal group with little inflammatory cell’s infiltration. In the 
treatment with an extract dose of 200 mg/kg BW + doxorubicin (Figure 1D) and the treatment 
group with an extract dose of 400 mg/kg BW + doxorubicin (Figure 1E), there was an improvement 
in the image of the rat liver tissue, which was indicated by the presence of normal hepatocytes 
more dominant than lysis (yellow triangle mark), slight signs of bleeding and congestion of blood 
vessels (red triangle mark) and sinusoids with lots of inflammatory cell infiltration (blue triangle 
mark).  The treatments of P. emblica extract at 200 mg/kg BW and 400 mg/kg BW in doxorubicin-
induced rats show an improvement in liver tissue.  The improvement of liver tissue was observed 
by the domination of normal hepatocytes than lysed cells, liver tissue repair, and increased 
inflammatory cell infiltration. 
Doxorubicin damage of liver tissue leads to histopathological changes. Doxorubicin 
accelerates the free radicals production such as hydroxyl radicals, superoxide, and hydrogen 
peroxide that can quickly react to lipid caused lipid peroxidation (Rashid et al., 2013). Doxorubicin 
generates high lipid peroxidation of liver tissue in terms of hepatocytes generation and necrosis 
parenchyma (Rahmani et al., 2018). Lipid peroxidation produces free radicals such as alkoxyl, 
aldehyde, and peroxyl,  which generate cellular damage and release of marker enzymes (Seif, 
2016). The significant stage in the pathogenesis of doxorubicin toxicity is the inflammation caused 
by endogenous and migrating leucocytes (Rahmani et al., 2018). Several studies reported that lipid 
peroxidation of the heart and liver caused by reactive oxygen species leads to tissue damage 
induced by doxorubicin (Dodda et al., 2014; Kolarovic et al., 2009; Yagmurca et al., 2004). The 
polyunsaturated fatty acids in membrane lipids, protein, genetic materials, and hepatocytes were 
attacked by ROS which damages the liver (Rahmani et al., 2018). Antioxidants participate in 
scavenging free radicals and inhibiting cellular damage by delaying the lipid peroxidation process 
(Gulcin, 2020; Nimse and Pal, 2015). The improvements in the accumulation of leukocytes in liver 
tissue caused by antioxidant agents have been reported in the previous study (Tardif et al., 2014). 
Findings from this study which exhibit liver tissue improvement by P. emblica extract at various 
concentration, in doxorubicin-induced hepatotoxicity rats, agree with previous studies done that 
observed the antioxidant activity of P. emblica L. scavenging the free radicals and leading to 
improve liver tissue in tested rats (Hasan et al., 2016; Yaman et al., 2016; Charoenteeraboon et al., 
2010; Tasduq et al., 2005). 
CONCLUSION 
The ethanol extract of Phyllanthus emblica L. contains alkaloids, flavonoids, phenolics, 
steroids/triterpenoids, terpenoids, and tannins. Both 200 mg/kg BW and 400 mg/kg BW of P. 
emblica extract show significantly decreased ALT and ALP levels and repair the liver tissue after 
doxorubicin-induced hepatotoxicity. These findings indicate the potential protective effect of P. 
emblica against doxorubicin toxicity in rat’s hepar.  
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